Influenza Diagnostics Market by Test type (Molecular (NASBA, RT-PCR, SAMBA, LAMP), Traditional (Viral Culture, Rapid Influenza Detection Test, Serology Test, DFA)), End user (Reference lab, Hospital, Clinic, Home Care Agency, POC) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: June 2, 2019
Clear
SKU: GMS845 Category:

The influenza diagnostics market is expected to reach USD 932.2 million by 2024, growing at CAGR by 7.67% from 2019 to 2024. Increased prevalence of influenza, increased funding for influenza diagnosis studies, and increased demand for faster diagnosis and control of influenza are key factors that are expected to drive the growth of the influenza diagnosis market in the coming years.

Influenza Diagnostics Market by Test type (Molecular (NASBA, RT-PCR, SAMBA, LAMP), Traditional (Viral Culture, Rapid Influenza Detection Test, Serology Test, DFA)), End user (Reference lab, Hospital, Clinic, Home Care Agency, POC) - 2019 to 2024 1

Influenza Diagnostics Market by Test type (Molecular (NASBA, RT-PCR, SAMBA, LAMP), Traditional (Viral Culture, Rapid Influenza Detection Test, Serology Test, DFA)), End user (Reference lab, Hospital, Clinic, Home Care Agency, POC) - 2019 to 2024 2

Influenza Diagnostics Market by Test type (Molecular (NASBA, RT-PCR, SAMBA, LAMP), Traditional (Viral Culture, Rapid Influenza Detection Test, Serology Test, DFA)), End user (Reference lab, Hospital, Clinic, Home Care Agency, POC) - 2019 to 2024 3

Influenza Diagnostics Market by Test type (Molecular (NASBA, RT-PCR, SAMBA, LAMP), Traditional (Viral Culture, Rapid Influenza Detection Test, Serology Test, DFA)), End user (Reference lab, Hospital, Clinic, Home Care Agency, POC) - 2019 to 2024 4

Influenza Diagnostics Market by Test type (Molecular (NASBA, RT-PCR, SAMBA, LAMP), Traditional (Viral Culture, Rapid Influenza Detection Test, Serology Test, DFA)), End user (Reference lab, Hospital, Clinic, Home Care Agency, POC) - 2019 to 2024 5

Influenza Diagnostics Market by Test type (Molecular (NASBA, RT-PCR, SAMBA, LAMP), Traditional (Viral Culture, Rapid Influenza Detection Test, Serology Test, DFA)), End user (Reference lab, Hospital, Clinic, Home Care Agency, POC) - 2019 to 2024 6

Influenza Diagnostics Market by Test type (Molecular (NASBA, RT-PCR, SAMBA, LAMP), Traditional (Viral Culture, Rapid Influenza Detection Test, Serology Test, DFA)), End user (Reference lab, Hospital, Clinic, Home Care Agency, POC) - 2019 to 2024 7

Influenza Diagnostics Market by Test type (Molecular (NASBA, RT-PCR, SAMBA, LAMP), Traditional (Viral Culture, Rapid Influenza Detection Test, Serology Test, DFA)), End user (Reference lab, Hospital, Clinic, Home Care Agency, POC) - 2019 to 2024 8

1 Global Influenza Diagnostics Market 
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Influenza Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Influenza Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Influenza Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Influenza Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Influenza Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Influenza Diagnostics Market – By Test Type (Market Size – & million/billion)
8.1 Traditional Diagnostic Tests
8.2 Viral Culture
8.3 Rapid Influenza Detection Tests (RIDT)
8.4 Direct Fluorescent Antibody (DFA) Tests
8.5 Serological Assays
8.6 Molecular Diagnostic Tests
8.7 RT-PCR
8.8 Other

9 Global Influenza Diagnostics Market – By End-User
9.1 Hospitals & Clinics
9.2 Reference Laboratories
9.3 Other

10 Global Influenza Diagnostics Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa

11 Global Influenza Diagnostics Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 Global Influenza Diagnostics Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 F. Hoffmann-La Roche AG
12.3 SA Scientific, Ltd.
12.4 Alere Inc.
12.5 Becton, Dickinson and Company
12.6 Thermo Fisher Scientific Inc.
12.7 Analytik Jena AG (A Subsidiary of Endress+Hauser AG)
12.8 Luminex Corporation
12.9 Quidel Corporation
12.10 Meridian Bioscience, Inc.
12.11 Diasorin S.P.A.
12.12 Company 11 & more

13 Global Influenza Diagnostics Market – Appendix
13.1 Sources
13.2 Abbreviations